ENTITY
Hugel Inc

Hugel Inc (145020 KS)

51
Analysis
Health CareSouth Korea
Hugel, Inc. is a Bio-pharmaceutical company that focuses on developing beauty/cosmetics related products. The Company's main products include botulinum toxin and fillers.
more
bullishHugel Inc
09 Nov 2024 15:14

Hugel Inc (145020 KS): Record High Quarterly Sales and Operating Profit in 3Q; US Launch to Start

​Hugel achieved revenue and operating profit of KRW105B and KRW53B in 3Q24, up 24% and 55%, YoY, respectively. The company plans to officially...

Logo
375 Views
Share
bullishHugel Inc
05 Mar 2024 15:12

Hugel Inc (145020 KS): Achieves Record High Revenue and Operating Profit in 4Q23

Hugel has received FDA approval for its botulinum toxin Letybo and becomes the only Korean company and one of the top 3 players globally that have...

Logo
552 Views
Share
bullishHugel Inc
11 Jun 2024 21:44

Hugel Inc (145020 KS): Favorable Court Ruling Paves US Entry; Record High 1Q Sales

​Hugel wins favorable preliminary ruling in US, revealing strain theft claim baseless. The company plans to launch Letybo in 2H24 in US, while...

Logo
306 Views
Share
21 Dec 2023 09:30

2023 in Rear Mirror View: Top Performers From My Global Healthcare Coverage Universe

​Despite ongoing recovery and fading effect of the COVID-19, healthcare companies had varying performances in 2023. From my coverage, the top...

Logo
607 Views
Share
03 Nov 2024 07:30

APAC Healthcare Weekly (Nov 3)- Eisai, Takeda, Shionogi, Astellas Pharma, Celltrion, Wuxi AppTec

Large APAC healthcare companies are reporting mixed earnings. Demography will play a key role in ensuring how the overall domestic demand scenario...

Logo
581 Views
Share
x